{"transactions":[{"id":1403402,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-18T21:52:25.000Z","date":"2024-09-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the \"Merger Agreement\"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation (\"Parent\") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the \"Effective Time\"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an \"Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the \"Closing Cash Consideration\") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to:"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right (\"CVR\") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of June 21, 2024 (the \"Merger Agreement\"), by and among the Issuer, ANI Pharmaceuticals, Inc., a Delaware corporation (\"Parent\") and ANIP Merger Sub INC., a Delaware corporation and a wholly owned indirect subsidiary of Parent, as of the effective time of the merger (the \"Effective Time\"), at the Effective Time, each stock option granted by the Issuer to purchase shares (each, an \"Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full, and each Option that was outstanding and unexercised which had a per share exercise price that was less than ) $5.50 in cash, without interest (such amount, the \"Closing Cash Consideration\") was converted into the right to receive the sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement) equal to:"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(A) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Option; multiplied by the number of shares underlying such Option and (B) one contingent value right (\"CVR\") representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between Parent and a rights agent."}],"balance_after":0,"derivative":{"exercise_price":2.99,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-101106","document":"tm2424353-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000110465924101106/tm2424353-2_4seq1.xml","form_type":"4"}},{"id":1666103,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-31T14:19:37.000Z","date":"2024-01-30","kind":"grant","planned":false,"acquired":true,"shares":20775,"price":0.71,"value":14750.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter."}],"balance_after":287256,"source":{"system":"sec-edgar","filing":"0001437749-24-002626","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774924002626/rdgdoc.xml","form_type":"4"}},{"id":1759567,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-17T14:44:31.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":14327,"price":1.11,"value":15902.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarte"}],"balance_after":266481,"source":{"system":"sec-edgar","filing":"0001437749-23-028341","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923028341/rdgdoc.xml","form_type":"4"}},{"id":1765108,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T17:28:10.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments beginning on August 1, 2023. Vests in full on the earlier of August 1, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, provided the Reporting Person provides continuous service to the Issuer through such date, with the final installment adjusted as necessary to avoid any fractional shares in any installment."}],"balance_after":50000,"derivative":{"exercise_price":2.99,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-23-051984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000095017023051984/ownership.xml","form_type":"4"}},{"id":1828363,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-18T16:52:43.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":9407,"price":1.435,"value":13499.045,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarte"}],"balance_after":252154,"source":{"system":"sec-edgar","filing":"0001437749-23-020111","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923020111/rdgdoc.xml","form_type":"4"}},{"id":1841713,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-30T14:52:36.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":44497,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":242747,"source":{"system":"sec-edgar","filing":"0001437749-23-018981","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923018981/rdgdoc.xml","form_type":"4"}},{"id":1917716,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-19T13:13:15.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":8613,"price":1.9,"value":16364.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter."}],"balance_after":198250,"source":{"system":"sec-edgar","filing":"0001437749-23-010613","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923010613/rdgdoc.xml","form_type":"4"}},{"id":2053383,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-18T19:06:41.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":4956,"price":3.125,"value":15487.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter."}],"balance_after":189637,"source":{"system":"sec-edgar","filing":"0001437749-23-001202","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923001202/rdgdoc.xml","form_type":"4"}},{"id":2136050,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-18T14:45:37.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":3981,"price":3.59,"value":14291.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter."}],"balance_after":184681,"source":{"system":"sec-edgar","filing":"0001437749-22-024293","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774922024293/rdgdoc.xml","form_type":"4"}},{"id":2206609,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-18T17:06:57.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":1758,"price":3.86,"value":6785.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter."}],"balance_after":180700,"source":{"system":"sec-edgar","filing":"0001437749-22-017242","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774922017242/rdgdoc.xml","form_type":"4"}},{"id":2218297,"issuer":{"id":9612,"kind":"organization","name":"SAFEGUARD SCIENTIFICS INC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-01T16:40:00.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":18942,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178942,"source":{"system":"sec-edgar","filing":"0001437749-22-016432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/86115/000143774922016432/rdgdoc.xml","form_type":"4"}},{"id":3514462,"issuer":{"id":157272,"kind":"organization","name":"SIERRA MONITOR CORP /CA/","symbol":"SRMC"},"owners":[{"id":87426,"kind":"person","name":"DeMont Ross D","position":1,"cik":"0001360838","reported_name":"DeMont Ross D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-05-23T08:30:40.000Z","date":"2019-05-20","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":3.25,"value":650000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Issuer common stock were cancelled and disposed at the effective time of the merger of Gateway Merger Sub, Inc. (\"Merger Sub\"), an indirect, wholly owned subsidiary of MSA Safety Incorporated (\"MSA\"), with and into the Issuer, pursuant to that certain Agreement and Plan of Merger dated March 28, 2019, among the Issuer, MSA and Merger Sub as a result of which Issuer became an indirect wholly owned subsidiary of MSA, in exchange for a cash payment of $3.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-19-008135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/100625/000149315219008135/ownership.xml","form_type":"4"}}]}